Refine by
Molecular Target Articles & Analysis
23 articles found
Since then, the BCL2 protein has become a key target in oncology and molecular biology. Functions and Roles in the Body Proteins encoded by the BCL2 gene family function primarily at the mitochondrial membrane, where they regulate the release of cytochrome c—a crucial step in the apoptotic process. ...
By leveraging fluorescent tags, our team can achieve a higher degree of specificity and sensitivity, enabling the detection of multiple targets simultaneously. This dual-color or multiplex approach enriches the data obtained, offering detailed insights into the relationships between different molecular targets within the same sample. ...
With continuous advancements in molecular biology, researchers are uncovering novel insights into how these proteins influence cellular health and disease development. ...
Traditional treatment paradigms often fail to provide the necessary specificity required to exclusively target ovarian cancer cells without affecting surrounding healthy tissue. Alfa Cytology’s Ovarian Cancer Therapy Development Services aim to bridge this gap by offering highly customized, robust therapeutic solutions that correspond with ovarian tumors’ unique ...
To date, scientists have leveraged various therapeutic avenues, including precision medicine, targeted therapies, and immunotherapy. However, issues such as drug delivery across the blood-brain barrier, tumor heterogeneity, and therapeutic resistance remain unresolved. ...
At that time, based on identification of recurrent genomic alterations in the eight most deadly cancers and their ranking on the ESMO Scale for Clinical Actionability of molecular Targets (ESCAT), NGS was recommended for advanced non-squamous non-small-cell lung cancer (NSCLC), prostate cancer, ovarian cancer and cholangiocarcinoma. ...
After the bait protein reacts with the target protein, a band corresponding to the target protein can be detected depending on the bait protein used.Experimental Materials1. ...
As sophisticated algorithms work their magic, predicting binding orientations and affinity scores, the intricate network of molecular interactions unfolds before our eyes. This dynamic interplay between computational algorithms and molecular models is the key to unlocking the mysteries that govern the interactions between drugs and protein ...
There are two types of metabolomics research methods: untargeted metabolomics and targeted metabolomics. Untargeted metabolomics analyzes the full metabolite profile without making presuppositions about specific metabolites and is relatively less reproducible and targeted. ...
Small molecule drugs are being developed to target and effectively treat brain tumors to improve therapeutic outcomes. ...
Apart from PROTAC, various targeted protein degradation (TPD) strategies are emerging, involving molecular glue, Autophagy-Targeting Chimera (AUTEC), Autophagosome Tethering Compound (ATTEC), and Autophagy Targeting Chimera (AUTOTAC). ...
By predicting the interactions between antibody drugs and molecular targets, antibody modeling services can enhance the affinity and specificity of antibody drugs and reduce the development time and cost. ...
It can label up to 8 samples at once depends on the iTRAQ kit, which contains reporter group, peptide reactive group and balance group. The molecular weight of reporter group ranging from 113Da to 121Da, and the related balance group ranging from 32Da to 24Da, which makes the total molecular weight to be 145Da. iTRAQ technology can compare proteins in many ...
This can be a difficult process considering what illness is being targeted. You can read more about bacteria and viruses and how they are treated here. ...
Therefore, HLA typing is beneficial for research on immune-related diseases, screening of vaccine and drug targets, research of evolution, and transplantation. However, due to its high degree of polymorphism, HLA forms a complex antigen typing system, resulting in no effective method to perform molecular typing with high throughput, high accuracy, and low cost ...
At present, technologies such as PROTACs, molecular glues, degradation tags, lysosome-targeted chimeras, and autophagosome-binding compounds have been developed in the field of TPD, which greatly expands the range of degradable target proteins. ...
Currently, targeted protein degradators are mainly divided into two types: small molecular "molecular glue" and biffunctional molecular degradators (PROTAC), both of which can mediate the binding and degradation of E3 ubiquitin ligase to the target protein. ...
The Dana-Farber Cancer Institute utilized SWOT analysis to targeted protein degradation drug development to better evaluate the approach's strengths, weaknesses, opportunities, and threats. ...
The use of experimental animal models in drug development aids in the understanding of disease and/or related conditions' origins, pathophysiological features, mechanisms, drug target identification, properties, toxicity and safety, pharmacokinetics, and efficacy evaluation, as well as the development of therapies. Despite the success of the Human Genome Project and other ...
Various calculations are encompassed in the basic experiments related to drug discovery and preparation, such as the calculation of excited state, charge density, molecular volume and so on. One of the vital and extensively applied computing technologies is virtual screening, which is abbreviated as VS. ...